Cyclodextrin solubilization of benzodiazepines: formulation of midazolam nasal spray
The DOI matches its Crossref record; 25 of the 26 references it cites were found in a registry or an index.
Abstract
The cyclodextrin solubilization of three benzodiazepines, i.e. alprazolam, midazolam and triazolam, was investigated. The cyclodextrin solubilization was enhanced through ring-opening of the benzodiazepine rings and ionization of the ring-open forms. Additional enhancement was obtained through interaction of a water-soluble polymer with the cyclodextrin complexes. The ring-opening was pH-dependent and completely reversible, the ring-open forms dominating at low pH but the ring-closed forms at physiologic pH. The ring-closed forms were rapidly regenerated upon elevation of pH. In freshly collected human serum in vitro at 37 degrees C, the half-life for the first-order rate constant for the ring-closing reaction was estimated to be less than 2 min for both alprazolam and midazolam. Midazolam (17 mg/ml) was solubilized in aqueous pH 4.3 nasal formulation containing 14% (w/v) sulfobutylether beta-cyclodextrin, 0.1% (w/v) hydroxypropyl methylcellulose, preservatives and buffer salts. Six healthy volunteers received 0.06 mg/kg midazolam intranasally and 2 mg intravenously, and blood samples were collected up to 360 min after the administration. Midazolam was absorbed rapidly reaching maximum serum concentrations of 54.3+/-5.0 ng/ml at 15+/-2 min. The elimination half-life of midazolam was 2.2+/-0.3 h and the absolute availability was 73+/-7%. All mean values+/-SEM.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, pain is common with intranasal midazolam administration, which may indicate irritation of the nasal mucosa due to the low pH (3-4.3) of the formulation (137-139).”
From Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics (2008) · cites this paper as [138]
Citations
Cites
Higuchi, T., & Connors, A. (1965) · Cited by 2,554
New trends in cyclodextrins and derivatives
Duchêne, D. (1991) · Cited by 356
Practical Handbook of Biochemistry and Molecular Biology
Fasman, G. D. (1989) · Medical Entomology and Zoology · Cited by 307
Kanto, J. H. (1985) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1985.tb03411.x · Cited by 237 · cited 1×
“…solutions but in some cases, e.g. in the case of alprazolam, midazolam and triazolam, this form is chemically stable and can contribute to the overall aqueous solubility of the drug (Cho et al., 1983; Kanto, 1985; Kurono et al., 1985; Kuwayama et al., 1986; Sbarbati Nudelman and de Waisbaum, 1995).”
BackgroundCyclodextrins as permeation enhancers: some theoretical evaluations and in vitro testing
Másson, M., Loftsson, T., Másson, G., & Stefánsson, E. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00182-5 · Cited by 213 · cited 1×
“However, excess cyclodextrin can decrease the drug bioavailability in the nasal spray solution (Masson et al., 1999).”
BackgroundThe effect of water-soluble polymers on drug-cyclodextrin complexation
Loftsson, T., Frikdriksdóttir, H., Sigurkdardóttir, A. M., & Ueda, H. (1994) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)90155-4 · Cited by 192 · cited 1×
“Previously, benzodiazepines have been solubilized through cyclodextrin complexation (Kraus et al., 1991; Loftsson et al., 1994).”
BackgroundChemical structure and properties of midazolam compared with other benzodiazepines.
Gerecke, M. (1983) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1983.tb02266.x · Cited by 165 · cited 2×
“3 (Gerecke, 1983).”
BackgroundInfluentialThe potential use of cyclodextrins in parenteral formulations.
Brewster, M. E., Simpkins, J. W., Hora, M., Stern, W. C., & Bodor, N. (1989) · PubMed · Cited by 138
Solubilization by Cosolvents I: Organic Solutes in Propylene Glycol-Water Mixtures
Yalkowsky, S. H., & Rubino, J. T. (1985) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600740410 · Cited by 137 · cited 1×
“Unfortunately, administration of non-aqueous drug formulations may result in pain, irritation and drug precipitation upon administration (Yalkowsky and Rubino, 1985; Way and Brazeau, 1999).”
BackgroundWalser, A., Benjamin, L. E., Flynn, T. J., Mason, C. J., Schwartz, R. S., & Fryer, R. I. (1978) · The Journal of Organic Chemistry · doi:10.1021/jo00399a029 · Cited by 127 · cited 1×
“5 (Walser et al., 1978).”
Cited by
Cyclodextrins in drug delivery: An updated review
Challa, R., Ahuja, A., Ali, J., & Khar, R. K. (2005) · AAPS PharmSciTech · doi:10.1208/pt060243 · Cited by 1,215
Cyclodextrins: structure, physicochemical properties and pharmaceutical applications
Jansook, P., Ogawa, N., & Loftsson, T. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.11.018 · Cited by 811
Cyclodextrins in drug delivery
Loftsson, T., Jarho, P., Másson, M., & Järvinen, T. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.1.335 · Cited by 793
“Recently, promising results from nasal delivery of dihydroergotamine [92], midazolam [93], acyclovir [94] and heparins [95] have been reported.”
BackgroundEvaluation of cyclodextrin solubilization of drugs
Loftsson, Þ., Hreinsdóttir, D., & Másson, M. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.05.042 · Cited by 736
Intranasal delivery: Physicochemical and therapeutic aspects
Costantino, H. R., Illum, L., Brandt, G., Johnson, P. H., & Quay, S. C. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.025 · Cited by 598
Metadata
- Authors
- Loftsson, T.
- Venue
- International Journal of Pharmaceutics
- Publisher
- Elsevier BV
- Published
- 2001-01-05
- Volume
- 212
- Issue
- 1
- Pages
- 29-40
- ISSN
- 0378-5173 (ISSN-L)
- OpenAlex
- W2169315622
- Cited by
- 116
- References
- 26
- Citations by year
- 2025: 2 · 2024: 2 · 2022: 6 · 2021: 3 · 2020: 2 · 2019: 8 · 2018: 1 · 2017: 5 · 2016: 4 · 2015: 6 · 2014: 3 · 2013: 6 · 2012: 3
- FWCI
- 3.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- International Journal of Pharmaceutics (publishedVersion)
- PubMed (publishedVersion)
- Hirsla (Landspítali University Hospital) (submittedVersion)
- Funders
- Háskóli Íslands
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Keywords
- benzodiazepines, midazolam, alprazolam, triazolam, ring opening, pH-dependent solubility, sulfobutylether-β-cyclodextrin, nasal spray formulation, intranasal drug delivery, bioavailability, pharmacokinetics, elimination half-life, human serum stability
- MeSH terms
- Administration, Intranasal, Adult, Animals, Chemistry, Pharmaceutical, Cyclodextrins, Female, Humans, Hydrogen-Ion Concentration, Male, Midazolam, Solubility, Anti-Anxiety Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cyclodextrin solubilization of benzodiazepines: formulation of midazolam nasal spray. https://app.cochat.ai/papers/10.1016/s0378-5173(00)00580-9
- The paper
- Loftsson, T. (2001). Cyclodextrin solubilization of benzodiazepines: formulation of midazolam nasal spray. International Journal of Pharmaceutics. https://doi.org/10.1016/s0378-5173(00)00580-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.